Cellectar Biosciences (CLRB) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Cellectar Biosciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $50K and 1 sold $733 of CLRB stock on the open market.
Get emailed when insiders cluster-buy stocks like CLRB
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CLRB insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $50K | 2 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $733 | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Cellectar Biosciences, Inc. insiders reported open-market purchases totaling $50K, while 1 insider reported sales totaling $733. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 11SEC | James V CarusoCEO | Buy | 8,68020,318 held (+75%) | $2.88 | $25K | -49.7% | — |
| May 11SEC | Jarrod LongcorCOO | Buy | 8,68020,451 held (+74%) | $2.88 | $25K | -49.7% | — |
| Dec 16SEC | John NeisDirector | Sell | 19810 held (−95%) | $3.70 | $733 | -60.8% | — |
Insiders at Cellectar Biosciences, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| James V CarusoCEO | $25K | — | May 11, 2026 | — |
| Jarrod LongcorCOO | $25K | — | May 11, 2026 | — |
| John NeisDirector | — | $733 | Dec 16, 2025 | — |
CLRB stock: common questions
Are Cellectar Biosciences, Inc. insiders buying CLRB stock?
In the past 12 months, 2 insiders reported open-market purchases of CLRB worth $50K. The latest was CEO James V Caruso bought $25K of CLRB at $2.88 — first open-market purchase in our records; raises the stake by 75%.
Are Cellectar Biosciences, Inc. insiders selling CLRB stock?
1 insiders reported sales worth $733 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CLRB's 52-week range?
Over the past year CLRB has traded between $1.40 and $4.98. It last closed at $1.45 on Oct 9, 2026.